Investor Presentaiton
Potential capital deployment* of ~$350 million at Dec. 30, 2022 to support growth and ROE
expansion, with a significant increase expected upon transition to IFRS 9 and IFRS 171
$
Organic growth
Investing in digital evolution
to propel growth
Acquisitions
To strengthen strategic positioning
Dividends
25%-35% payout ratio target range
Based on core earnings
NCIB
Up to 5% of oustanding shares
(between Nov. 14, 2022 and Nov 13, 2023)
1 Expected estimated combined impact of IFRS 9 and IFRS 17 transition on January 1, 2022, according to information available as at Dec. 31, 2022.
9
* This item is a non-IFRS measure; see the "Non-IFRS and Additional Financial Measures" section at the end of this document for relevant information about such measures.View entire presentation